Loretta Nastoupil, MD
10 years treating Diffuse Large B Cell Lymphoma
The focus of my research has been on examining disparities in lymphoma survival to identify opportunities to design and implement rational clinical trials aimed at improving outcomes for high-risk patients. I have completed analyses using large databases in follicular lymphoma and diffuse large B-cell lymphoma (DLBCL) identifying characteristics that predict for inferior outcomes. My early efforts in this arena identified disparities in the use of potentially-curative, chemo-immunotherapy in the treatment of DLBCL patients. This study demonstrated that race and insurance status were associated with significant differences in the administration of chemo-immunotherapy among US patients with DLBCL.
MD Anderson Cancer Center: 1515 Holcombe Blvd, Houston, TX 77030, USA